Independent evaluation validates UNITAID’s approach
Cites it as model for global development
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
IPM grows 4.1 per cent, valued at Rs 5939 crore in November 2012
Abbott, Sun Pharma cross Rs 300 crore in monthly sales
ABLE India invites entries for Best Biotech Innovation Awards
Winners to be awarded during the 10 th year anniversary of ABLE on March 11, 2013 in New Delhi
FDA approves Abraxane for the first-line treatment of advanced non-small cell lung cancer
Approval based on significantly improved overall response rates in all patients regardless of histology
India, Iran finalise rupee as trade currency
Pharmexcil to take high level 25-member delegation to Tehran from Dec 17-19
Indonesian Pharmacopoeia to adopt and adapt USP-NF Standards
USP and Indonesia’s National Agency for Drug and Food Control enter a five-year agreement to collaborate in harmonising of…
UNITAID $120 million grant to focus on childhood HIV/AIDS, malaria and TB
Approved four 'market entry' grants to help manufacturers of 'point-of-care' HIV diagnostic machines
Union Health Ministry highlights shortage of drug inspectors in LS
Rs 2 crore assigned to strengthen drug control departments in this FY
Claris in JV with Otsuka, Mitsui for injectables
Deal gives Otsuka entry into IV solution/clinical nutrition business in India, emerging markets
EMA sets out next steps on access to clinical trial data
Invites expressions of interest for advisory groups
CARE Research releases pharma, CRAMS performance updates
CRO segment to rise but likely to get hit by global economic crisis in near term
DIA begins transition to new executive leadership
DIA will announce plans for the executive director search in January 2013
Manjiri Gharat elected to FIP CPS Executive Committee Member
Will contribute to community pharmacy development globally for a four year term from 2012-16
Strides, Eli Lily tie up to tap emerging markets
Agila Specialties to make, Eli Lilly to market branded generic cancer meds
Venus gets DCGI approval for phase III trial of cancer detection NCE
Venus is planning to launch this NCE by last quarter of 2013 in India
Piramal’s subsidiary, DRG acquires Abacus International
Acquisition adds significant global market access capabilities to DRG
Bribery, corruption key compliance risks to pharma cos: KPMG India Fraud Survey 2012
Procurement, sales & distribution and inventory amongst top three most vulnerable processes to fraud risks in the sector